[Médecins Sans Frontières] accused the biotechnology company Gilead Sciences Inc. of breaking its promise to make its effective AIDS drug widely available throughout the Third World...In April 2003, Gilead said it would make the drug available in all of Africa plus 15 other developing nations "at no profit." The company has since announced it has expanded its access program to a total of 97 countries...Gilead spokeswoman...said...the company has applied for regulatory approval in about half the covered countries and expects to apply for the rest sometime this year.